Portfolio managers should consider choosing CLOs and ABS over corporate credit and agency MBS over Treasuries in 2025, says ...

Incyte's revenues continues to grow, with full-year 2024 revenues reaching $4.2 billion, driven by JAKAFI and OPZELURA. Click ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Marshall Crenshaw: 8 p.m. Thursday and Friday, March 20-21, at Space, 1245 Chicago Ave., Evanston. Pop, with Rachael Sage on ...

Growth concerns are mounting for Southeast Asia's largest economy after President Prabowo Subianto issued directives to ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...

Speculation about potential changes in the finance ministry’s leadership further worsened the decline before a government denial ...

Steward Partners Investment Advisory LLC trimmed its position in shares of PENN Entertainment, Inc. (NASDAQ:PENN – Free ...

US investment firms are rushing to grab a greater chunk of Europe’s market for active exchange-traded funds, an industry projected to grow to $1 trillion in assets over the coming years. JPMorgan ...

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Robert Half Inc. (NYSE:RHI – Free Report) by 16.6% during the fourth quarter, according to the company in its most recent filing with the ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

Sky, formerly MakerDAO, announced last year its plan to allocate $1 billion of reserve assets in tokenized real-world asset ...